AVE 25.0% 0.3¢ avecho biotechnology limited

small cap investor presentation april 8, page-3

  1. 2,006 Posts.
    I'm glad someone's finally picked up on this.

    With or without her trademark glasses I think Esra is superb. It's comforting to know we have such a competent CEO at the helm.

    I trust all longterm holders and traders alike will load up on stock in the next few days to be ready for another tilt at 20+ cents? The offical launch of the "Bodyshape" products can't be too far away (by the end of April as stated) and it's bound to attract another bout of media and shareprice attention.

    No sense in not being fully loaded with POH on that happy occasion.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.